A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

Clinical trial NCT07601074 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07601074
Sponsor: Daré Bioscience, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Human Papilloma Virus (HPV)High-risk Human Papillomavirus Infection

Start date: 2026-06-01
Primary completion: 2027-10-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.